American International Group, Inc. Abbott Laboratories Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $117,514 - $129,790	-1,073 Reduced 0.24%	439,712 $50 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $924,086 - $1.13 Million	-10,246 Reduced 2.27%	440,785 $48.5 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $923,106 - $1.11 Million	-9,663 Reduced 2.1%	451,031 $43.7 Million
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $302,541 - $337,094	3,002 Added 0.66%	460,694 $50.2 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $194,398 - $228,818	2,007 Added 0.44%	457,692 $46.3 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $1.23 Million - $1.44 Million	-12,938 Reduced 2.76%	455,685 $50 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.12 Million - $1.3 Million	-11,575 Reduced 2.41%	468,623 $45.3 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $1.87 Million - $2.26 Million	-18,326 Reduced 3.68%	480,198 $52.2 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $1.62 Million - $1.98 Million	-14,224 Reduced 2.77%	498,524 $59 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $378,707 - $463,705	-3,278 Reduced 0.64%	512,748 $72.2 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $2.56 Million - $2.83 Million	-21,941 Reduced 4.08%	516,026 $61 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $1.1 Million - $1.3 Million	-10,403 Reduced 1.9%	537,967 $62.4 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $552,254 - $650,639	-5,074 Reduced 0.92%	548,370 $65.7 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $786,975 - $857,577	-7,495 Reduced 1.34%	553,444 $60.6 Million
Q3 2020 Nov 04, 2020	SELL	$91.64 - $111.29 $2.14 Million - $2.6 Million	-23,362 Reduced 4.0%	560,939 $61 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $352,604 - $451,290	4,605 Added 0.79%	584,301 $53.4 Million
Q1 2020 May 04, 2020	SELL	$62.82 - $91.86 $5.56 Million - $8.13 Million	-88,472 Reduced 13.24%	579,696 $45.7 Million
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $1.6 Million - $1.78 Million	20,352 Added 3.14%	668,168 $58 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $268,680 - $291,333	-3,283 Reduced 0.5%	647,816 $54.2 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $2.61 Million - $3.05 Million	-35,830 Reduced 5.22%	651,099 $54.8 Million
Q1 2019 May 06, 2019	SELL	$66.22 - $80.06 $321,100 - $388,210	-4,849 Reduced 0.7%	686,929 $54.9 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $4.43 Million - $5.02 Million	-67,628 Reduced 8.91%	691,778 $50 Million
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $2.2 Million - $2.66 Million	36,231 Added 5.01%	759,406 $55.7 Million
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $159,526 - $176,069	2,771 Added 0.38%	723,175 $44.1 Million
Q1 2018 May 07, 2018	BUY	$56.27 - $63.62 $539,010 - $609,415	9,579 Added 1.35%	720,404 $43.2 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $452,092 - $484,012	8,422 Added 1.2%	710,825 $40.6 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $33.8 Million - $37.7 Million	702,403	702,403 $37.5 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.05 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.76 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.29 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account